Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients

Clinical trial NCT00718341 · COMPLETED

Trial details

NCT number: NCT00718341
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2008-06-01
Primary completion: 2009-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.